Ratings changes for Verrica Pharmaceuticals, Geron, Sana Biotechnology, Lexicon Pharmaceuticals, Sana Biotechnology, Charter Communications, Bicara Therapeutics and more...Text "MarketBeat" to 68285 to get SMS breaking news alerts for stocks on your watchlist and other special reports. Learn More.

November 5th, 2024

2024's Must-Watch Stocks! (ad)

Welcome to a year of unparalleled opportunities! Dive into our exclusive guide, "9 Stocks Set to Soar," meticulously selected to elevate your portfolio in 2024. Step into 2024 with confidence and the right assets at your fingertips. Click below to opt-in and receive up to two additional free bonus subscriptions. Unsubscribe at any time.

[Unlock Your Report Now]

Today's Top Stories

These 2 Big Players Are Set to Compete With Elon Musk’s Starlink

By Leo Miller | November 5, 2024 09:12 AM

Did you know you can now trade Bitcoin in your regular brokerage account? (Ad)

By DTI

Strike at Boeing was part of a new era of labor activism long in decline at US work places

By The Associated Press | November 5, 2024 09:47 AM

Intel: Is Now the Time to Be Brave?

By Sam Quirke | November 4, 2024 10:33 AM

Crypto’s next big bull run? (Ad)

By Weiss Ratings

South Korea fines Meta $15 million for illegally collecting information on Facebook users

By The Associated Press | November 5, 2024 02:59 AM

NXP Semiconductors Nears Rock Bottom: A Buy Signal Is Expected

By Thomas Hughes | November 5, 2024 08:51 AM

Quick Links

MarketBeat All Access

⭕ [URGENT] Buy Alert just triggered (ad)

My absolute favorite stock just hit a critical "buy now" trigger price.

Click here for the ticker >>>

Your Watchlist

You have not added any stocks to your watchlist.

Click here to add stocks to your watchlist

Analysts' Upgrades

Alkermes (NASDAQ:ALKS) was upgraded by analysts at Stifel Nicolaus from a "hold" rating to a "buy" rating. They now have a $36.00 price target on the stock, up previously from $25.00. This represents a 28.0% upside from the current price of $28.12.

argenx (NASDAQ:ARGX) was upgraded by analysts at Scotiabank from a "sector perform" rating to a "sector outperform" rating. They now have a $715.00 price target on the stock, up previously from $439.00. This represents a 20.3% upside from the current price of $594.40.

Brightcove (NASDAQ:BCOV) was upgraded by analysts at Lake Street Capital from a "hold" rating to a "buy" rating. They now have a $3.50 price target on the stock, up previously from $2.75. This represents a 30.1% upside from the current price of $2.69.

Century Casinos (NASDAQ:CNTY) was upgraded by analysts at JMP Securities from a "market perform" rating to an "outperform" rating. They now have a $5.00 price target on the stock. This represents a 17.6% upside from the current price of $4.25.

Carvana (NYSE:CVNA) was upgraded by analysts at Morgan Stanley from an "underweight" rating to an "equal weight" rating. They now have a $260.00 price target on the stock, up previously from $110.00. This represents a 11.1% upside from the current price of $234.12.

Chevron (NYSE:CVX) was upgraded by analysts at DZ Bank AG from a "hold" rating to a "buy" rating. They now have a $170.00 price target on the stock. This represents a 10.3% upside from the current price of $154.07.

Deutsche Lufthansa (OTCMKTS:DLAKY) was upgraded by analysts at Morgan Stanley from an "underweight" rating to an "equal weight" rating.The current price is $6.66.

eBay (NASDAQ:EBAY) was upgraded by analysts at Sanford C. Bernstein from a "market perform" rating to an "outperform" rating. They now have a $70.00 price target on the stock. This represents a 14.4% upside from the current price of $61.20.

HomeStreet (NASDAQ:HMST) was upgraded by analysts at Wedbush from a "neutral" rating to an "outperform" rating. They now have a $12.00 price target on the stock. This represents a 24.9% upside from the current price of $9.61.

IDACORP (NYSE:IDA) was upgraded by analysts at Bank of America Co. from a "neutral" rating to a "buy" rating. They now have a $117.00 price target on the stock, up previously from $113.00. This represents a 7.4% upside from the current price of $108.89.

Disc Medicine (NASDAQ:IRON) was upgraded by analysts at Morgan Stanley from an "equal weight" rating to an "overweight" rating. They now have a $85.00 price target on the stock. This represents a 43.4% upside from the current price of $59.28.

MDU Resources Group (NYSE:MDU) was upgraded by analysts at Bank of America Co. from a "neutral" rating to a "buy" rating. They now have a $17.00 price target on the stock, down previously from $31.00. This represents a 7.2% upside from the current price of $15.86.

Medifast (NYSE:MED) was upgraded by analysts at DA Davidson from an "underperform" rating to a "neutral" rating. They now have a $17.00 price target on the stock, up previously from $16.50. This represents a 13.3% downside from the current price of $19.60.

MasTec (NYSE:MTZ) was upgraded by analysts at Truist Financial Co. from a "hold" rating to a "buy" rating. They now have a $173.00 price target on the stock, up previously from $133.00. This represents a 26.4% upside from the current price of $136.88.

View More Upgrades

Man who Predicted Trump 2016 Win: “Prepare for Election Meltdown” (ad)

Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs…

A predicted Trump would win.

You won’t believe what he’s predicting now.

Click here to see it because it’s a SHOCKER…

Analysts' Downgrades

Air France-KLM (OTCMKTS:AFLYY) was downgraded by analysts at Morgan Stanley from an "equal weight" rating to an "underweight" rating.The current price is $0.95.

Affiliated Managers Group (NYSE:AMG) was downgraded by analysts at TD Cowen from a "buy" rating to a "hold" rating. They now have a $177.00 price target on the stock, down previously from $226.00. This represents a 0.4% upside from the current price of $176.24.

BCE (NYSE:BCE) (TSE:BCE) was downgraded by analysts at Edward Jones from a "buy" rating to a "hold" rating.The current price is $28.74.

BCE (NYSE:BCE) (TSE:BCE) was downgraded by analysts at Canaccord Genuity Group Inc. from a "buy" rating to a "hold" rating.The current price is $28.74.

Celanese (NYSE:CE) was downgraded by analysts at Wells Fargo & Company from an "overweight" rating to an "equal weight" rating. They now have a $115.00 price target on the stock, down previously from $165.00. This represents a 22.0% upside from the current price of $94.25.

Cognex (NASDAQ:CGNX) was downgraded by analysts at Truist Financial Co. from a "buy" rating to a "hold" rating. They now have a $43.00 price target on the stock, down previously from $46.00. This represents a 7.1% upside from the current price of $40.14.

Dollar Tree (NASDAQ:DLTR) was downgraded by analysts at Telsey Advisory Group from an "outperform" rating to a "market perform" rating. They now have a $75.00 price target on the stock, down previously from $95.00. This represents a 12.3% upside from the current price of $66.79.

Hudson Technologies (NASDAQ:HDSN) was downgraded by analysts at Craig Hallum from a "buy" rating to a "hold" rating. They now have a $7.00 price target on the stock, down previously from $10.00. This represents a 16.1% upside from the current price of $6.03.

Hudson Technologies (NASDAQ:HDSN) was downgraded by analysts at Roth Mkm from a "buy" rating to a "neutral" rating. They now have a $7.00 price target on the stock. This represents a 16.1% upside from the current price of $6.03.

IDEAYA Biosciences (NASDAQ:IDYA) was downgraded by analysts at Leerink Partners from an "outperform" rating to a "market perform" rating. They now have a $27.00 price target on the stock, down previously from $41.00. This represents a 5.5% downside from the current price of $28.58.

Marqeta (NASDAQ:MQ) was downgraded by analysts at Monness Crespi & Hardt from a "buy" rating to a "neutral" rating. They now have a $7.50 price target on the stock. This represents a 107.8% upside from the current price of $3.61.

Marqeta (NASDAQ:MQ) was downgraded by analysts at William Blair from an "outperform" rating to a "market perform" rating.The current price is $3.61.

Marqeta (NASDAQ:MQ) was downgraded by analysts at Wells Fargo & Company from an "overweight" rating to an "equal weight" rating. They now have a $5.00 price target on the stock, down previously from $7.00. This represents a 38.5% upside from the current price of $3.61.

Marqeta (NASDAQ:MQ) was downgraded by analysts at KeyCorp from an "overweight" rating to a "sector weight" rating.The current price is $3.61.

Marqeta (NASDAQ:MQ) was downgraded by analysts at Deutsche Bank Aktiengesellschaft from a "buy" rating to a "hold" rating. They now have a $4.00 price target on the stock, down previously from $9.00. This represents a 10.8% upside from the current price of $3.61.

Neumora Therapeutics (NASDAQ:NMRA) was downgraded by analysts at JPMorgan Chase & Co. from an "overweight" rating to a "neutral" rating. They now have a $15.00 price target on the stock, down previously from $18.00. This represents a 36.1% upside from the current price of $11.02.

Retail Opportunity Investments (NASDAQ:ROIC) was downgraded by analysts at KeyCorp from an "overweight" rating to a "sector weight" rating.The current price is $16.86.

Sana Biotechnology (NASDAQ:SANA) was downgraded by analysts at JMP Securities from an "outperform" rating to a "market perform" rating.The current price is $3.17.

Tactile Systems Technology (NASDAQ:TCMD) was downgraded by analysts at BTIG Research from a "buy" rating to a "neutral" rating.The current price is $13.25.

Tactile Systems Technology (NASDAQ:TCMD) was downgraded by analysts at Oppenheimer Holdings Inc. from an "outperform" rating to a "market perform" rating.The current price is $13.25.

Verrica Pharmaceuticals (NASDAQ:VRCA) was downgraded by analysts at Royal Bank of Canada from an "outperform" rating to a "sector perform" rating.The current price is $0.83.

View More Downgrades

Bill Gates’s Next Big AI Bet: Stargate (ad)

In February 2016… when almost nobody was talking about artificial intelligence….

I picked Nvidia as one of my favorite stocks.

Shares have jumped by more than 20,000% since then.

I believe we are about to do it again with this new AI project called Stargate

Analysts' New Coverage

Alarm.com (NASDAQ:ALRM) is now covered by analysts at Jefferies Financial Group Inc.. They set a "buy" rating and a $65.00 price target on the stock. This represents a 18.3% upside from the current price of $54.96.

Bicara Therapeutics (NASDAQ:BCAX) is now covered by analysts at Rodman & Renshaw. They set a "buy" rating and a $48.00 price target on the stock. This represents a 92.3% upside from the current price of $24.96.

CalAmp (NASDAQ:CAMP) is now covered by analysts at JPMorgan Chase & Co.. They set an "overweight" rating and a $23.00 price target on the stock. This represents a 179.8% upside from the current price of $8.22.

CalAmp (NASDAQ:CAMP) is now covered by analysts at Piper Sandler. They set an "overweight" rating and a $18.00 price target on the stock. This represents a 119.0% upside from the current price of $8.22.

CalAmp (NASDAQ:CAMP) is now covered by analysts at William Blair. They set an "outperform" rating on the stock.The current price is $8.22.

CalAmp (NASDAQ:CAMP) is now covered by analysts at Leerink Partners. They set an "outperform" rating and a $17.00 price target on the stock. This represents a 106.8% upside from the current price of $8.22.

CeriBell (NASDAQ:CBLL) is now covered by analysts at Canaccord Genuity Group Inc.. They set a "buy" rating and a $30.00 price target on the stock. This represents a 12.9% upside from the current price of $26.58.

CeriBell (NASDAQ:CBLL) is now covered by analysts at William Blair. They set an "outperform" rating on the stock.The current price is $26.58.

CeriBell (NASDAQ:CBLL) is now covered by analysts at TD Cowen. They set a "buy" rating and a $31.00 price target on the stock. This represents a 16.6% upside from the current price of $26.58.

CeriBell (NASDAQ:CBLL) is now covered by analysts at JPMorgan Chase & Co.. They set an "overweight" rating and a $32.00 price target on the stock. This represents a 20.4% upside from the current price of $26.58.

CeriBell (NASDAQ:CBLL) is now covered by analysts at Bank of America Co.. They set a "buy" rating and a $32.00 price target on the stock. This represents a 20.4% upside from the current price of $26.58.

Celestica (NYSE:CLS) (TSE:CLS) is now covered by analysts at Barclays PLC. They set an "overweight" rating and a $91.00 price target on the stock. This represents a 20.5% upside from the current price of $75.54.

CMS Energy (NYSE:CMS) is now covered by analysts at Jefferies Financial Group Inc.. They set a "buy" rating and a $76.00 price target on the stock. This represents a 10.5% upside from the current price of $68.76.

Krispy Kreme (NASDAQ:DNUT) is now covered by analysts at Morgan Stanley. They set an "equal weight" rating and a $14.00 price target on the stock. This represents a 18.1% upside from the current price of $11.85.

Eaton (NYSE:ETN) is now covered by analysts at Sanford C. Bernstein. They set an "outperform" rating and a $382.00 price target on the stock. This represents a 13.8% upside from the current price of $335.65.

Fabrinet (NYSE:FN) is now covered by analysts at Needham & Company LLC. They set a "buy" rating and a $280.00 price target on the stock. This represents a 24.1% upside from the current price of $225.59.

Geron (NASDAQ:GERN) is now covered by analysts at HC Wainwright. They set a "buy" rating and a $8.00 price target on the stock. This represents a 93.2% upside from the current price of $4.14.

Hubbell (NYSE:HUBB) is now covered by analysts at Sanford C. Bernstein. They set an "outperform" rating and a $535.00 price target on the stock. This represents a 23.1% upside from the current price of $434.72.

TuHURA Biosciences (NASDAQ:HURA) is now covered by analysts at Maxim Group. They set a "buy" rating and a $15.00 price target on the stock. This represents a 206.1% upside from the current price of $4.90.

MSA Safety (NYSE:MSA) is now covered by analysts at B. Riley. They set a "buy" rating and a $200.00 price target on the stock. This represents a 21.2% upside from the current price of $164.95.

Sable Offshore (NYSE:SOC) is now covered by analysts at Johnson Rice. They set a "buy" rating and a $30.00 price target on the stock. This represents a 32.3% upside from the current price of $22.68.

Upstream Bio (NASDAQ:UPB) is now covered by analysts at TD Cowen. They set a "buy" rating on the stock.The current price is $26.63.

Upstream Bio (NASDAQ:UPB) is now covered by analysts at William Blair. They set an "outperform" rating on the stock.The current price is $26.63.

Upstream Bio (NASDAQ:UPB) is now covered by analysts at JPMorgan Chase & Co.. They set an "overweight" rating and a $38.00 price target on the stock. This represents a 42.7% upside from the current price of $26.63.

Upstream Bio (NASDAQ:UPB) is now covered by analysts at Piper Sandler. They set an "overweight" rating and a $75.00 price target on the stock. This represents a 181.6% upside from the current price of $26.63.

ProShares UltraPro Short Nasdaq Biotechnology (NASDAQ:ZBIO) is now covered by analysts at Rodman & Renshaw. They set a "buy" rating and a $34.00 price target on the stock. This represents a 70.4% upside from the current price of $19.95.

View More New Coverage

Calendars from MarketBeat

U.S. Analyst Ratings

Corporate Buybacks

Cryptocurrencies

Dividend Declarations

Earnings Announcements

Earnings Conference Calls

Economic Reports

Gap Up/Down Stocks

Insider Trades

Initial Public Offerings (IPOs)

Most Active Stocks

Percentage Gainers/Decliners

Sector Performance

Short Interest

Stock Splits

Unusual Options Volume

Unusual Trading Volume

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial